The mission of NovaMedica is to create comprehensive therapy solutions for patients and their families to ensure the best result with the help of innovative and efficient medical technologies. The company offers patients new pharmaceutical drugs, technologies and other innovative products and services that have successfully proven themselves in various other countries but have not been available in Russia or the CIS before. Our solutions are intended for medical assistance at all stages, from diagnostics and prevention of diseases to treatment and continuous protection.
We are also prepared to actively communicate with patients and patient organizations in Russia and the CIS to raise awareness of new treatment methods in all areas where our company has competences.
Pharmacovigilance is the science and activities relating to the detection, assessment, understanding and prevention of adverse effects or any other drug-related problem (World Health Organization).
Please inform us of any adverse events that might be associated with our pharmaceutical products:
· via the hotline: +7 (800) 222-49-08
· by e-mail:
Pharmaceutical safety information is extremely important as it helps ensure that medicinal products are being used in an effective and safe manner.
NovaMedica in the TOP-1000 Russian Managers Rating
28 September 2024
06 September 2024
NovaMedica expands its line of products for the treatment of Alzheimer’s disease
22 August 2024
Health Minister: “Russian scientists are creating drugs for Alzheimer’s and Parkinson’s deseases”
10 October 2024
Russia proposes to establish a prize for new drug development technologies
10 October 2024
First real-world study reveals encouraging efficacy for cell therapy
10 October 2024
Results from Global Pharmaceutical Customer Experience survey
09 October 2024